Skip to main contentSkip to navigation
Sirius Investors

PXMBF Stock: Paxman AB (publ) Stock Price, Analysis & Insights

Get live PXMBF stock price $3.50, comprehensive Paxman AB (publ) stock analysis, charts, news, and expert forecast. Real-time PXMBF stock data and investment insights.

3.50
0.00%Today
PXMBFPaxman AB (publ) • Other OTC • Healthcare
Market Cap
149.87M
Volume
600
52W High
3.50
52W Low
3.50

Loading chart data...

Paxman AB (publ) (PXMBF) Overview

Paxman AB (publ) (PXMBF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, PXMBF trades at $3.50 with a market capitalization of 149.87M . Over the past 52 weeks, PXMBF has traded between $3.50 and $3.50 , with the current price positioned at approximately NaN% of this range . The stock currently trades...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Devices)
  • Market cap: 149.87M
  • Current price: $3.50
  • 52-week range: $3.50 - $3.50
  • P/E ratio: 29.17

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Paxman AB (publ), operating alongside its subsidiaries, specializes in engineering and marketing the Paxman scalp cooling system. This innovative solution aims to significantly mitigate hair loss experienced by patients undergoing chemotherapy, with ...

Company Information

CEO
Richard Paxman
Sector
Healthcare
Industry
Medical - Devices
Employees
105

Contact Information

Address
Pirgatan 13
Country
SE

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 29.2)

Lower volatility stock (Beta: 0.47) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Paxman AB (publ) shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Paxman AB (publ)
  • Investors should consider how Paxman AB (publ) fits within their overall portfolio allocation

Market Cap

149.87M

P/E Ratio (TTM)

29.17

Beta

0.47

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.